武田制药 (TAK.N)

+ 收藏

现金流量表(武田制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2025年三季报2025年中报2025年一季报2024年年报2024年三季报2024年中报2024年一季报
起始日期 2025-04-012025-04-012025-04-012024-04-012024-04-012024-04-012024-04-01
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
报表年结日 0331033103310331033103310331
原始币种 日元日元日元日元日元日元日元
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
经营活动产生的现金流量:
 净利润(元) 会员可见会员可见会员可见会员可见211,241,000,000.00187,406,000,000.00136,603,000,000.00
 折旧及摊销(元) 会员可见会员可见会员可见会员可见571,627,000,000.00384,672,000,000.00192,220,000,000.00
 基于股票的补偿费(元) 会员可见会员可见会员可见会员可见55,240,000,000.0036,940,000,000.0015,386,000,000.00
 减值及拨备(元) 会员可见会员可见会员可见会员可见38,227,000,000.0036,065,000,000.0026,000,000,000.00
 资产处置损益(元) 会员可见会员可见会员可见会员可见3,059,000,000.002,457,000,000.002,088,000,000.00
 投资损益(元) 会员可见会员可见会员可见会员可见125,560,000,000.0086,976,000,000.0022,785,000,000.00
 重估盈余(元) 会员可见会员可见会员可见会员可见2,253,000,000.002,172,000,000.00-12,000,000.00
 权益性投资损益(元) 会员可见会员可见会员可见会员可见3,199,000,000.001,247,000,000.00712,000,000.00
 经营业务调整其他项目(元) ---会员可见71,142,000,000.0068,570,000,000.00-
 存货的减少(增加)(元) 会员可见会员可见会员可见会员可见-29,981,000,000.00-51,218,000,000.00-10,079,000,000.00
 预付款项及其他应收款减少(增加)(元) 会员可见会员可见会员可见会员可见18,231,000,000.004,272,000,000.002,310,000,000.00
 应收账款及票据减少(增加)(元) --会员可见会员可见-45,105,000,000.00-57,779,000,000.00-47,744,000,000.00
 应付账款及票据增加(减少)(元) 会员可见会员可见会员可见会员可见-17,448,000,000.00-37,079,000,000.00-37,455,000,000.00
 应付税项(元) 会员可见会员可见会员可见会员可见-120,349,000,000.00-89,081,000,000.00-37,811,000,000.00
 经营业务其他项目(元) 会员可见会员可见会员可见会员可见-51,875,000,000.00-124,355,000,000.00-94,701,000,000.00
 经营活动产生的现金流量净额(元) 会员可见会员可见会员可见会员可见835,023,000,000.00451,267,000,000.00170,304,000,000.00
投资活动产生的现金流量:
 购买固定资产支付的现金(元) 会员可见会员可见会员可见会员可见-152,002,000,000.00-106,914,000,000.00-57,441,000,000.00
 处置固定资产收到的现金(元) 会员可见会员可见会员可见会员可见46,000,000.0038,000,000.009,000,000.00
 购买无形资产及其他资产支付的现金(元) 会员可见会员可见会员可见会员可见-103,115,000,000.00-91,552,000,000.00-80,357,000,000.00
 投资支付现金(元) 会员可见会员可见会员可见会员可见-68,686,000,000.00-4,619,000,000.00-7,663,000,000.00
 收购附属公司(元) 会员可见会员可见-会员可见---
 出售附属公司(元) 会员可见会员可见-会员可见---
 投资业务其他项目(元) 会员可见会员可见会员可见会员可见-23,622,000,000.00-28,777,000,000.00-11,242,000,000.00
 投资活动产生的现金流量净额(元) 会员可见会员可见会员可见会员可见-347,379,000,000.00-231,824,000,000.00-156,693,000,000.00
融资活动产生的现金流量:
 回购股份(元) 会员可见会员可见会员可见会员可见-1,882,000,000.00-1,882,000,000.00-1,882,000,000.00
 股息支付(元) 会员可见会员可见会员可见会员可见-292,760,000,000.00-147,309,000,000.00-138,110,000,000.00
 贷款收益(元) 会员可见会员可见会员可见会员可见-76,619,000,000.00383,441,000,000.00440,529,000,000.00
 其他筹资活动产生的现金流量净额(元) 会员可见会员可见会员可见会员可见-12,953,000,000.00-9,120,000,000.00-4,654,000,000.00
 筹资业务其他项目(元) 会员可见会员可见会员可见会员可见-65,419,000,000.00-18,793,000,000.0020,498,000,000.00
 融资活动产生的现金流量净额(元) 会员可见会员可见会员可见会员可见-449,633,000,000.00206,336,000,000.00316,381,000,000.00
期间变动其他项目(元) 会员可见会员可见会员可见会员可见-1,685,000,000.00-24,564,000,000.0017,220,000,000.00
现金及现金等价物期初余额(元) 会员可见会员可见会员可见会员可见457,800,000,000.00457,800,000,000.00457,800,000,000.00
现金及现金等价物增加(减少)额(元) 会员可见会员可见会员可见会员可见38,010,000,000.00425,779,000,000.00329,991,000,000.00
现金及现金等价物期末余额(元) 会员可见会员可见会员可见会员可见494,126,000,000.00859,015,000,000.00805,012,000,000.00
补充资料其他项目(元) --会员可见---803,532,000,000.00
公告日期 2026-01-292025-10-302025-07-302025-06-252025-01-302024-10-312024-07-31
会计准则 国际会计准则国际会计准则国际会计准则国际会计准则国际会计准则国际会计准则国际会计准则
审计意见
核数师

前瞻产业研究院